[Controversies and future of the approach to cardiovascular disease in HIV patients].
| Autor: | Bernardino de la Serna JI; Unidad VIH, Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España. jibernardino.hulp@salud.madrid.org, Arribas López JR |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Enfermedades infecciosas y microbiologia clinica [Enferm Infecc Microbiol Clin] 2009 Sep; Vol. 27 Suppl 1, pp. 48-53. |
| DOI: | 10.1016/S0213-005X(09)73445-7 |
| Abstrakt: | Cardiovascular diseases are an increasing problem in patients with HIV infection. The causes of the increased cardiovascular risk in HIV-infected patients are multifactorial. Currently, the question of which factor has the most weight in this equation - whether traditional risk factors, the virus per se or antiretroviral therapy - remains to be determined. The absolute risk of cardiovascular disease in a particular patient depends on the composite risk profile. At present, there are no data to support a distinct approach to cardiovascular risk evaluation in HIV-infected patients. Cardiovascular risk equations should be incorporated into routine daily clinical assessment in order to identify patients in need of specific interventions. (Copyright 2009 Elsevier España S.L. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|